FeesSafety
Pluang+

J.P. Morgan launches tokenized money-market funds on Solana for U.S. investors

Protocol Fundamentals
23 Oct 2026
Tokenpost
View Source
Bullish
J.P. Morgan launches tokenized money-market funds on Solana for U.S. investors

J.P. Morgan Asset Management has made its tokenized money-market funds, MONY and JLTXX, available on the Solana blockchain for qualified U.S. investors. MONY is a private-placement fund, while JLTXX is a government money market fund supporting stablecoin issuers under the GENIUS Act. Together, these funds held $844 million on Ethereum as of October 11, offering investors a new digital asset investment option through Morgan Money. This move expands access to traditional money-market products via blockchain technology.

J.P. Morgan Asset Management's tokenized funds on Solana provide context for digital asset interest. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 23, 2026 17:51 WIB: out of 50 priced cryptocurrencies, 25 rose and 23 fell. Kusama (KSM) rose 2.42% to Rp72.936 with 100% buy orders and an 80-day typical hold time. Basic Attention Token (BAT) increased 2.35% to Rp3.150 with 66% buy orders and a 93-day hold time. Fantom (FTM) declined 2.05% to Rp11.382 with an 88-day hold time.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
19 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App